Kangji Medical Holdings Limited (HKG: 9997)
Hong Kong
· Delayed Price · Currency is HKD 6.04
-0.12 (-1.95%)
Jan 3, 2025, 4:08 PM HKT
Kangji Medical Holdings Revenue
Kangji Medical Holdings had revenue of 458.41M CNY in the half year ending June 30, 2024, with 37.94% growth. This brings the company's revenue in the last twelve months to 980.85M, up 14.37% year-over-year. In the year 2023, Kangji Medical Holdings had annual revenue of 926.02M with 17.76% growth.
Revenue (ttm)
980.85M CNY
Revenue Growth
+14.37%
P/S Ratio
6.71
Revenue / Employee
977.91K CNY
Employees
1,003
Market Cap
7.30B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 26.04B |
| Hansoh Pharmaceutical Group Company | 13.00B |
| JD Health International | 58.84B |
| WuXi Biologics | 18.39B |
| Sinopharm Group | 634.32B |
| Innovent Biologics | 8.01B |
| Sino Biopharmaceutical | 29.86B |
| CSPC Pharmaceutical Group | 33.53B |